Browsing Tag
United Kingdom
851 posts
Hays plc (LSE: HAS) shares jump as profit outlook improves despite weak hiring market
Hays plc rallied as profit guidance improved despite falling fees, raising the key question: is HAS seeing a turnaround or only a cost-led reprieve?
Scancell Holdings (LSE:SCLP): Can a Nasdaq deal fund its pivotal melanoma trial?
Scancell has strong melanoma data, but Phase 3 still needs funding. A Nasdaq deal could reset LSE:SCLP, or leave investors facing dilution and deal risk.
ImmuPharma (LSE: IMM) has two biotech catalysts, but can P140 finally deliver the deal?
ImmuPharma targets a P140 licensing deal while LSE trades below its Lanstead benchmark. The next partner decision could reshape the biotech story.
H-Power (AIM: HPOW): Can August certification finally turn hydrogen orders into revenue?
H-Power has hydrogen orders and £17.4 million of cash, but August LC30 certification must turn demand into revenue before investor confidence returns.
Levi Strauss (LEVI) delivers Q2 2026 double beat and raises FY revenue growth to 7-7.5%
Levi Strauss (LEVI) delivers Q2 double beat, raises FY revenue growth to 7-7.5% and lifts dividend 14%. Tariff-adjusted guidance signals margin recovery ahead.
Andy Burnham pledges UK hard power rebuild as Labour leadership handover nears
Andy Burnham’s defence pledge signals that Britain’s likely next prime minister wants to connect military renewal with regional industry, European security ties and a tougher response to a more dangerous world.
Kalyan Jewellers (NSE: KALYANKJIL) rebounds 5% as Q1 growth tests valuation reset
Kalyan Jewellers rebounded after Q1 revenue grew 38%. Formal results must prove whether growth, Candere and recycled gold can support margins.
Vistry Group (LSE: VTY) slides 9% as £30m H1 loss tests partnership reset
Vistry fell after warning of a £30m H1 loss, higher discounts and a CFO exit. September’s CEO review must prove the reset can work.
Otsuka’s Astex signs $490m-plus Genentech breast cancer partnership
Astex signs a $490 million-plus Genentech breast cancer deal. Discover how Otsuka’s fragment platform could reshape Roche oncology research and returns.
Qatar accuses Iran after LNG tanker strike as Hormuz security plan faces immediate test
A drone strike on the Qatari LNG carrier Al Rekayyat and damage to other tankers have exposed the fragility of Gulf shipping, just as France and Britain seek support for a multinational Strait of Hormuz mission.